Rad Chat

Trigger Warning: this episode discusses cancer. Episode 218 which is part of the living with and beyond cancer series.Description: In this educational episode, Naman Julka-Anderson and Jo McNamara sit down Dr. Aruni Ghose, a Specialty Doctor in Oncology at the South East Wales Immunotherapy Toxicity Service, Velindre Cancer Centre in Cardiff and Research Fellow in Cardio-Oncology at the Hatter Cardiovascular Institute, University College London, UK. He is an NHS Clinical Entrepreneur, Chief Medical Officer at British based OncoFlow AI Cancer CoPilot. He is Director of Operations at the International Urology Cancer Summit, Steering Committee of the London Global Cancer Week Cancer Health Disparities, Oncology Council of the Royal Society of Medicine, Collaborator at the Lancet Commission on Cancer Control in the Commonwealth and a Future Cancer Leader at the UK and Ireland Global Cancer Network.In this episode, Naman Julka-Anderson and Jo McNamara talk to Dr. Aruni Ghose about his career, health inequalities and OncoFlow, which uses AI to help healthcare professionals involved in cancer care create personalised management plans for cancer patients.CPD Reflection Points:One area of your practice where AI could improve patient care, efficiency or decision-making.What benefits this could bring to patients and healthcare professionals.What would need to be considered before introducing AI into your practice.Reflect on a patient you have cared for: What individual factors influenced their care? Could AI have helped identify or respond to any of these factors? What aspects of personalised care could AI never replace?Complete this form for your accredited digital badge: Digital Badge Form.Links from the Episode:Dr Aruni Ghose LinkedIn Profile Onco Flow AI Research links from the Episode:Dr Aruni Ghose Scholarly ActivityRad Chat Links:Rad Chat WebsiteLink TreeFacebookInstagramLinkedInTikTokBlueSkyYouTubeCredits: Music and jingle credits: Dr. Ben Potts and Adam Cooke.© Rad Chat 2025. All rights reserved.  We (or our licensors) own all intellectual property rights in this podcast and all related content, online and offline.  You may not use, copy, modify, download, archive, reproduce, distribute, display, publish, licence, create derivative works from or commercially exploit any part of our content unless we expressly agree in writing.  You must not use any images, audio, video, graphics or clips separately from their accompanying context.  Please acknowledge Rad Chat (and any identified contributors) clearly whenever referencing or sharing our content.

Trigger Warning: this episode discusses cancer, diagnostic imaging and cancer treatment. Bonus Episode in paid partnership with Ergéa. Description: In this episode, Naman Julka-Anderson and Jo McNamara sit down with Donna Hughes and Carol Scott.Donna is an experienced therapeutic radiographer with a long and varied career in radiotherapy practice and service development. She currently works for Oxford University Hospitals NHS Foundation Trust as the Lead Radiographer for the radiotherapy satellite centre in Milton Keynes, supporting the delivery of high-quality, patient-centred care. Donna trained in England and spent the first half of her career working in Ireland before returning to the UK. Her clinical experience includes roles in neuro-oncology and stereotactic radiosurgery (SRS), as well as contributing to the implementation of an MR Linac service in the private sector. She is particularly passionate about patient care and the people she works alongside. Carol is a senior therapeutic radiographer and Radiotherapy Services Manager at Oxford University Hospitals NHS Foundation Trust. She has extensive experience in radiotherapy service leadership, advanced radiotherapy technologies and stereotactic radiotherapy, and has held senior clinical leadership roles including Deputy Clinical Director for Oncology. Carol has played a key role in the development of innovative radiotherapy services at Oxford, including stereotactic and image-guided radiotherapy, and has contributed to radiotherapy development and commissioning at a national level through NHS England.We discuss how the role of a managed equipment service supports staff by freeing up clinical time, supporting with recruitment and retention of staff, as well as sustainability and future proofing digital solutions. CPD Reflection Points:Reflect on how the current management and maintenance of radiotherapy or diagnostic equipment affects your department’s efficiency, staff experience, and patient care. Identify one area where a managed equipment service could reduce downtime, delays, or administrative burden. What impact could this have on staff morale, workload, and the patient experience?Consider how reliable, modern and well-maintained equipment could influence recruitment and retention within your service. Reflect on whether access to contemporary technology, effective technical support and a well-functioning working environment could make your department more attractive to current and prospective staff. What changes could help demonstrate that your organisation is investing in its workforce?Reflect on the potential of managed equipment services to future-proof radiotherapy and diagnostic services. Consider how planned replacement, proactive maintenance, training and access to technical expertise could support staff to work confidently with evolving technology. How could this contribute to workforce development, job satisfaction and the delivery of safe, timely and high-quality patient care?Complete this form for your accredited digital badge: Digital Badge Form.Links from the Episode:ErgéaClinical Managed Services including Managed Maintenance ServicesManaged Services GuideRad Chat Links:Rad Chat WebsiteLink TreeFacebookInstagramLinkedInTikTokBlueSkyYouTubeCredits: Music and jingle credits: Dr. Ben Potts and Adam Cooke.© Rad Chat 2025. All rights reserved.  We (or our licensors) own all intellectual property rights in this podcast and all related content, online and offline.  You may not use, copy, modify, download, archive, reproduce, distribute, display, publish, licence, create derivative works from or commercially exploit any part of our content unless we expressly agree in writing.  You must not use any images, audio, video, graphics or clips separately from their accompanying context.  Please acknowledge Rad Chat (and any identified contributors) clearly whenever referencing or sharing our content.

Trigger Warning: this episode discusses cancer, cancer treatment, benign conditions, side effects and long term conditions.Episode 217: Part of the Education and workforce development series (part 72)Description: In this powerful episode, Naman Julka-Anderson and Jo McNamara sit down with Dr. Richard Shaffer is a Radiation Oncologist and a prominent expert in the use of radiotherapy for treating benign disease, including Dupuytren’s, Ledderhose, plantar fasciitis, Achilles tendinopathy, keloid scars, osteoarthritis, tendinopathy and bursitis. Since starting his practice in 2011, Dr. Shaffer has treated more than 3000 benign patients and provided training and mentoring to fellow consultants starting benign radiotherapy practices. He co-wrote the 2015 Royal College of Radiologists guidelines for benign conditions and is the founder and President of the International Society for Radiotherapy for Benign Conditions (www.iorbc.com).This episode is a deep dive into Richard’s career, history of radiotherapy for benign conditions, dose and fractionation along with potential side effects.CPD Reflection Points:Identify common benign indications that can be treated by radiotherapy.Understand appropriate dose and fractionation for benign conditions.Recognise the risks and benefits of treating benign disease with ionising radiation.Complete this form for your accredited digital badge: Digital Badge Form.Links from the Episode:Theralife clinicsDupuytrens UKJoint pain practice Radiotherapy Academy for Benign ConditionsInternational organisation for radiotherapy for benign conditionsResearch links from the Episode:Recommendations for using radiotherapy for benign disease in the UKRadiotherapy for benign disease; assessing the risk of radiation-induced cancer following exposure to intermediate dose radiationRad Chat Links:Rad Chat WebsiteLink TreeFacebookInstagramLinkedInTikTokBlueSkyYouTubeCredits: Music and jingle credits: Dr. Ben Potts and Adam Cooke.© Rad Chat 2025. All rights reserved.  We (or our licensors) own all intellectual property rights in this podcast and all related content, online and offline.  You may not use, copy, modify, download, archive, reproduce, distribute, display, publish, licence, create derivative works from or commercially exploit any part of our content unless we expressly agree in writing.  You must not use any images, audio, video, graphics or clips separately from their accompanying context.  Please acknowledge Rad Chat (and any identified contributors) clearly whenever referencing or sharing our content.

Trigger Warning: this episode discusses healthcare.Episode216: Part of the education and workforce development series (Part 72)Description: In this educational episode, Naman Julka-Anderson and Jo McNamara sit down with Christopher Tuckett, a senior NHS leader and physiotherapist with a career spanning clinical practice, service improvement and strategic AHP leadership. He has led across acute, community and national settings, with a strong focus on quality, value and workforce optimisation. Christopher is currently undertaking a PhD exploring the acceptability of healthcare interventions, including digital models of care, bringing fresh insight into how technology, behaviour and service design intersect to improve outcomes and productivity.This episode is a deep dive into life as an AHP, career development, leadership and research into digital models of care. CPD Reflection Points:What is one aspect of your work that creates significant value, but is currently difficult to measure or demonstrate? How could you make that value more visible?How has the episode changed your thinking about productivity in healthcare? Identify one measure of activity in your service that could be better linked to quality, outcomes or patient impact.What is one thing you could do differently when communicating the value of your role, or service to senior leaders, or finance colleagues? What will you do differently as a result?Complete this form for your accredited digital badge: Digital Badge Form.Links from the Episode:Christopher TuckettDigital Services for Integrated CareRad Chat Links:Rad Chat WebsiteLink TreeFacebookInstagramLinkedInTikTokBlueSkyYouTubeCredits: Music and jingle credits: Dr. Ben Potts and Adam Cooke.© Rad Chat 2025. All rights reserved.  We (or our licensors) own all intellectual property rights in this podcast and all related content, online and offline.  You may not use, copy, modify, download, archive, reproduce, distribute, display, publish, licence, create derivative works from or commercially exploit any part of our content unless we expressly agree in writing.  You must not use any images, audio, video, graphics or clips separately from their accompanying context.  Please acknowledge Rad Chat (and any identified contributors) clearly whenever referencing or sharing our content.

Trigger Warning: this episode discusses cancer, cancer treatment, sex, infertility and late effects.​​​​Episode 217: Part of the living with and beyond cancer series (Part 76)​​​​Description: In this insightful episode, Naman Julka-Anderson and Jo McNamara sit down with Steph Davies. She is the founder of Life after Cancer, a UK not-for-profit supporting adults after cancer treatment through coaching, peer support, expert sessions, workshops and community connection. After her own experience of Hodgkin lymphoma, she created Life after Cancer to help others navigate the often-overlooked challenges that can follow treatment. A trained coach and NLP practitioner, she combines professional expertise with lived experience. Steph has collaborated with organisations including NHS England, UCLH, Macmillan and Nuffield Health, and is passionate about improving support and helping people rebuild confidence, identity and wellbeing after treatment.​​​​CPD Reflection Points:​​What aspects of post-treatment care are currently underrepresented in your practice?​​How might fear of recurrence, identity loss, or reduced confidence present in patients you see?​​What changes could you make to better acknowledge these needs?​​How do your current communication styles support or limit patient empowerment?​​Can you identify a recent interaction where a coaching approach might have improved the outcome?​​What small communication changes could you trial in your next clinical shift?​​Are you confident in your knowledge of post-treatment support services?​​How often do you initiate conversations about life after treatment?​​What barriers might prevent effective signposting in your role?​​​​Complete this form for your accredited digital badge: Digital Badge Form.​​​​Links from the Episode:​​Life after cancer​​Rad Chat Links:​​Rad Chat Website​​Link Tree​​Facebook​​Instagram​​LinkedIn​​TikTok​​BlueSky​​YouTube​​​​Credits: Music and jingle credits: Dr. Ben Potts and Adam Cooke.​​​​© Rad Chat 2025. All rights reserved.  ​​We (or our licensors) own all intellectual property rights in this podcast and all related content, online and offline.  ​​You may not use, copy, modify, download, archive, reproduce, distribute, display, publish, licence, create derivative works from or commercially exploit any part of our content unless we expressly agree in writing.  ​​You must not use any images, audio, video, graphics or clips separately from their accompanying context.  ​​Please acknowledge Rad Chat (and any identified contributors) clearly whenever referencing or sharing our content.